BOSTON SCIENTIFIC ANNOUNCES RESULTS FOR FIRST QUARTER 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- CoreWeave stock drops on dilution fears and debt concerns
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
Boston Scientific (BSX) Reports In-Line Q1 EPS
April 27, 2022 6:34 AM EDTBoston Scientific (NYSE: BSX) reported Q1 EPS of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $3.03 billion versus the consensus estimate of $2.95 billion.
GUIDANCE:
Boston Scientific sees Q2 2022 EPS of $0.41-$0.43. Boston Scientific sees Q2... More



